Discover how dopamine’s unexpected role in breaking down harmful plaques could revolutionize Alzheimer's treatment and ...

Researchers have discovered that suppressing a nucleolar complex can reduce Alzheimer’s-related protein toxicity. Scientists ...

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder hallmarked with intracellular neurofibrillary tangles and extracellular amyloid β (Aβ) plaques. AD is the most common cause of ...

Melatonin is a supplement most often taken as a sleep aid. Some research shows it may have benefits for people with Alzheimer’s disease, but current evidence is mixed. Melatonin is a hormone ...

On the other hand, sleep problems like insomnia and sleep apnea can lead to serious health issues and even increase the risk ...

Researchers challenge everything we know about Alzheimer's disease with shocking new findings about amyloid beta protein's ...

A treatment to reverse Alzheimer's Disease could be available in five years, it has been revealed. Experiments on mice have indicated that a new vaccine not only halts the advance of the disease ...

Alzheimer's disease is a major cause of dementia, with early symptoms including memory loss, poor judgment, and low mood.

Adult aging remains the greatest risk factor for Alzheimer’s disease (AD), with its prevalence doubling approximately every ...

Troculeucel is under clinical development by NKGen Biotech and currently in Phase II for Alzheimer’s Disease. According to GlobalData, Phase II drugs for Alzheimer’s Disease have a 36% phase ...